|
CFL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.966400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.001200E-01 |
| Normal-vs-Stage2 |
1.041190E-01 |
| Normal-vs-Stage3 |
4.678100E-02 |
| Normal-vs-Stage4 |
2.570300E-04 |
| Stage1-vs-Stage2 |
1.650770E-01 |
| Stage1-vs-Stage3 |
9.399500E-02 |
| Stage1-vs-Stage4 |
2.263100E-03 |
| Stage2-vs-Stage3 |
8.271200E-01 |
| Stage2-vs-Stage4 |
2.567400E-01 |
| Stage3-vs-Stage4 |
3.718400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.289700E-02 |
| Normal-vs-AfricanAmerican |
1.987790E-01 |
| Normal-vs-Asian |
2.979800E-01 |
| Caucasian-vs-AfricanAmerican |
7.319200E-01 |
| Caucasian-vs-Asian |
7.643600E-01 |
| AfricanAmerican-vs-Asian |
8.578600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.279900E-02 |
| Normal-vs-Female |
1.379030E-01 |
| Male-vs-Female |
6.698600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.486650E-01 |
| Normal-vs-Age(41-60Yrs) |
7.820600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.758900E-04 |
| Normal-vs-Age(81-100Yrs) |
8.991500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.037200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.550600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.214400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.754200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.076200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.610000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.797600E-01 |
| Normal-vs-Grade 2 |
2.368400E-01 |
| Normal-vs-Grade 3 |
1.439770E-01 |
| Normal-vs-Grade 4 |
3.99030000000078E-05 |
| Grade 1-vs-Grade 2 |
2.020200E-01 |
| Grade 1-vs-Grade 3 |
1.339030E-01 |
| Grade 1-vs-Grade 4 |
4.540300E-02 |
| Grade 2-vs-Grade 3 |
4.969800E-01 |
| Grade 2-vs-Grade 4 |
1.401170E-03 |
| Grade 3-vs-Grade 4 |
4.744300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.477200E-01 |
| Normal-vs-ccB subtype |
8.374000E-02 |
| ccA subtype-vs-ccB subtype |
6.344200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.153590E-01 |
| Normal-vs-N1 |
4.20500001485635E-09 |
| N0-vs-N1 |
1.226520E-04 |
|
|
